"Neuroscience Group is committed to excellence in brain, spine and pain care. It is a multi-specialty practice focused on the comprehensive diagnosis and treatment of the nervous system: brain, spine, and spinal cord. Neuroscience Group is the only medical practice in northeast Wisconsin that combines neurology, neurosurgery, orthopedic spine surgery, interventional pain management, speech therapy and physical therapy."

During the past decade, Neuroscience Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neuroscience Group" #1 collaborator was "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator and "EMD Serono" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Neuroscience Group" are "Migraine" (1 trials) and "Relapsing-remitting Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Neuroscience Group" in a lesser frequency.

Most popular intervention types in "Neuroscience Group" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Eptinezumab" (1 trials), "Placebo" (1 trials), "Rebif" (1 trials) and "Tecfidera" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neuroscience Group" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Neuroscience Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Neuroscience Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Neuroscience Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".